Hi SoT, thanks for this post. I am left very confused (which is a common thing for me), as it seems to me that the two IP candidates are now gazumped as the target remedy for both was/is Progranulin. What does this do to the CNS programme?Quite a medium term gap. We now need to rely on the Ocular programme and will particularly depend on the Diabetic RP programme due to much higher case numbers and higher returns.
PYC, page-42
Add PYC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
11.0¢ |
Change
-0.005(4.35%) |
Mkt cap ! $513.2M | |||
| Open | High | Low | Value | Volume |
| 11.5¢ | 11.8¢ | 11.0¢ | $297.5K | 2.621M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 12 | 1372418 | 11.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 11.5¢ | 390472 | 6 |
View Market Depth
| Last trade - 16.10pm 19/07/2024 (20 minute delay) ? |
| PYC (ASX) Chart |